Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Novoheart International Limited is managing a patent portfolio in the Medical Devices & Mechanical Engineering technology area with 3 pending office actions. These actions are distributed across 3 distinct examiners, indicating a range of review within the USPTO. The busiest examiner, MCCALISTER, WILLIAM M, is currently handling 1 pending action. This suggests that the workload is spread, as no examiner is managing more than 1 of the company's 3 pending actions. The focus on 3 distinct examiners suggests that the company's current legal strategy involves multiple points of contact.
The portfolio's reach extends across 3 distinct art units, which matches the number of distinct examiners involved. This variety shows that the company's 3 pending office actions involve different technical specialties or mechanical applications. For practitioners, this means that the prosecution strategy must be adapted to the specific standards of 3 different art units and 3 different examiners. The presence of 3 pending actions across these units reflects a distributed prosecution profile where each matter is handled by a unique examiner. MCCALISTER, WILLIAM M holds 1 pending action, making their specific examination style a factor in the company's current prosecution outcomes.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCALISTER, WILLIAM M | 1 | 69.2% | +19.6% |
| EDWARDS, LYDIA E | 1 | 60.1% | +6.0% |
| REGLAS, GILLIAN CHELSEA | 1 | 32.3% | +37.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17143795 | MICROFABRICATED DEVICES AND HIGH THROUGHPUT ASSAYS FOR MODULATORS OF CELL BEHAVIOR | REGLAS, GILLIAN CHELSEA | 14d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17143795 | MICROFABRICATED DEVICES AND HIGH THROUGHPUT ASSAYS FOR MODULATORS OF CELL BEHAVIOR | REGLAS, GILLIAN CHELSEA | 14d |
| 18260754 | LOW PRESSURE VALVE ASSEMBLIES | MCCALISTER, WILLIAM M | — |
| Art Unit | Apps |
|---|---|
| 3753 | 1 |
| 1796 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18260754 | LOW PRESSURE VALVE ASSEMBLIES | MCCALISTER, WILLIAM M | 3753 | §103 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 18016254 | A Multi-Sample System for Engineered Tissue Strip Assays | EDWARDS, LYDIA E | 1796 | §103 | Final Rejection | 27d | Pending | Jan 13, 2023 |
| 17143795 | MICROFABRICATED DEVICES AND HIGH THROUGHPUT ASSAYS FOR MODULATORS OF CELL BEHAVIOR | REGLAS, GILLIAN CHELSEA | 1632 | §103§112 | Non-Final OA | 14d | Pending | Jan 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNovoheart International Limited has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
William M Mccalister has the most, with 1 of Novoheart International Limited's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
